Opus Genetics (IRD) Stock Price, Quote, News & History | Benzinga

SPY777.48−0.08%QQQ742.21−0.51%BTC/USD83,119.50+1.69%DIA516.22−0.33%GLD380.88−0.33%TLT78.35+0.38%

Opus Genetics Inc (IRD) Stock Price, Quote, News & History

IRDNASDAQ

Trade with Public

Trade with Public

$4.42

-0.22-4.74%

Last update: Oct 13, 1:38 PM

$4.70

0.061.29%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$4.76

Close

-

Volume / Avg.

544.17K / 2.35M

Day Range

$4.42 - $4.42

52 Wk Range

1.70 - 7.07

Market Cap

$386.03M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

16.45%

Days to Cover

6.05

Recent Opus Genetics Inc News

Crude Oil Jumps Over 3%; Core & Main Posts Upbeat Q2 Earnings

U.S. stocks fell Wednesday as energy rose and discretionary slumped; Signet and Opus surged, while ServiceTitan plunged. Oil jumped 3.6%.

Avi Kapoor

Gene Therapy at Lower Dose Shows Vision Improvements, Opus Genetics Says

Opus Genetics posts positive Phase 1/2 trial results for OPGx-BEST1 and aligns with the FDA on Phase 3 plans for 2027.

Vandana Singh

Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday

U.S. stocks fell, but Caleres surged 14% on strong results and higher guidance. Opus Genetics, Signet and Oddity also posted big gains.

Avi Kapoor

Dow Tumbles 350 Points; Signet Jewelers Shares Jump Following Upbeat Q2 Earnings

U.S. stocks fell Wednesday, led by a 350-point Dow drop. Signet surged on strong earnings; oil, gold and silver prices climbed.

Avi Kapoor

Top 3 Health Care Stocks That May Rocket Higher In July

Health care sector oversold - buying opportunities in undervalued companies. RSI compares stock strength on up/down days, below 30 is oversold.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-40.67M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

97.15M

Free Cash Flow (TTM)

-40.67M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

56.48M

Analyst Trends and Forecast

4

Jun

3

Jul

1

Aug

5

Sep

2

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$334.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

39.42

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-27.71%

Earnings Yield % (FWD)

-12.24%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.16

Company Debt

Total Debt

$36.20M

LT Debt

$36.20M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$88.81M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-